Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-01 00:00:00 ET · period of report 2025-04-29 · accession 0001415889-25-011692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $13.45 | +87.3K | 73.5K | New | +$1.17M |
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Moat Ross | Chief COMMERCIAL Off | S - Sale+OE | $25.96 | -87.3K | 9,415 | -90% | -$2.27M |
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -87.3K | 37.5K | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 7,432 | $11.97 | 58,143 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-05-01 | S | D | 23,234 | $28.02 | 9,415 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $28.00 and $28.11. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2025-05-01 | M | A | 1,157 | $17.76 | 32,649 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-05-01 | M | A | 8,671 | $11.10 | 31,492 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-05-01 | M | A | 13,406 | $13.35 | 22,821 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 15,000 | $15.52 | 24,415 | D | — | — | |
| 7 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 20,000 | $15.50 | 44,415 | D | — | — | |
| 8 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 6,296 | $12.97 | 50,711 | D | — | — | |
| 9 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 15,307 | $10.76 | 73,450 | D | — | — | |
| 10 | Common | Class A Ordinary Share | 2025-04-29 | S | D | 64,035 | $25.21 | 9,415 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.00 and $25.45. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 11 | Derivative | Share Option | 2025-04-29 | M | D | 7,432 | $0.00 | 27,252 | D | $11.97 · — to 2032-08-31 | 7,432 Class A Ordinary Share | (F6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |
| 12 | Derivative | Share Option | 2025-04-29 | M | D | 20,000 | $0.00 | 0 | D | $15.50 · — to 2030-09-09 | 20,000 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 13 | Derivative | Share Option | 2025-04-29 | M | D | 15,000 | $0.00 | 0 | D | $15.52 · — to 2030-03-12 | 15,000 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 14 | Derivative | Share Option | 2025-04-29 | M | D | 15,307 | $0.00 | 23,361 | D | $10.76 · — to 2033-03-31 | 15,307 Class A Ordinary Share | (F7) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023. |
| 15 | Derivative | Share Option | 2025-05-01 | M | D | 13,406 | $0.00 | 27,594 | D | $13.35 · — to 2029-06-30 | 13,406 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 16 | Derivative | Share Option | 2025-05-01 | M | D | 8,671 | $0.00 | 21,059 | D | $11.10 · — to 2032-04-06 | 8,671 Class A Ordinary Share | (F8) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |
| 17 | Derivative | Share Option | 2025-04-29 | M | D | 6,296 | $0.00 | 1,658 | D | $12.97 · — to 2031-09-01 | 6,296 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. |
| 18 | Derivative | Share Option | 2025-05-01 | M | D | 1,157 | $0.00 | 37,511 | D | $17.76 · — to 2033-08-31 | 1,157 Class A Ordinary Share | (F9) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |